Novozymes AS (NSISb)

Currency in DKK
411.7
+9.0(+2.23%)
Closed·
NSISb Scorecard
Full Analysis
Net income is expected to grow this year
NSISb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
403.2411.7
52 wk Range
368.5489.4
Key Statistics
Prev. Close
402.7
Open
404.1
Day's Range
403.2-411.7
52 wk Range
368.5-489.4
Volume
956.89K
Average Volume (3m)
494.12K
1-Year Change
-10.91%
Book Value / Share
172.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NSISb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
478.7
Upside
+16.27%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Novozymes AS News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Novozymes AS Company Profile

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, and microbial and medical cleaning services. Further, it offers corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; and fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, sewage, and renewable diesel solutions; and agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. It also provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Industry
Chemicals
Employees
10582
Market
Denmark

Compare NSISb to Peers and Sector

Metrics to compare
NSISb
Peers
Sector
Relationship
P/E Ratio
45.5x21.9x0.3x
PEG Ratio
0.290.030.00
Price/Book
2.4x1.3x1.6x
Price / LTM Sales
6.3x0.9x1.3x
Upside (Analyst Target)
14.2%12.8%18.6%
Fair Value Upside
Unlock9.6%0.3%Unlock

Analyst Ratings

11 Buy
4 Hold
2 Sell
Ratings:
17 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 478.7
(+16.27% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.99%
Dividend Yield
1.57%
Industry Median 1.61%
Annualised payout
6.45
Paid annually
5-Years Growth
+4.09%
Growth Streak

Earnings

Latest Release
Aug 20, 2025
EPS / Forecast
0.29 / --
Revenue / Forecast
1.02B / 7.75B
EPS Revisions
Last 90 days

NSISb Income Statement

People Also Watch

263.40
ESLX
-1.16%
654.30
ASML
-0.89%
358.8
NOVOb
+0.59%
93.60
SGOB
+0.17%
226.00
TCFP
-0.53%

FAQ

What Stock Exchange Does Novozymes AS Trade On?

Novozymes AS is listed and trades on the Copenhagen Stock Exchange stock exchange.

What Is the Stock Symbol for Novozymes AS?

The stock symbol for Novozymes AS is "NSISb."

What Is the Novozymes AS Market Cap?

As of today, Novozymes AS market cap is 191.51B.

What Is Novozymes AS's Earnings Per Share (TTM)?

The Novozymes AS EPS (TTM) is 1.99.

From a Technical Analysis Perspective, Is NSISb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Novozymes AS Stock Split?

Novozymes AS has split 1 times.

How Many Employees Does Novozymes AS Have?

Novozymes AS has 10582 employees.

What is the current trading status of Novozymes AS (NSISb)?

As of 29 Aug 2025, Novozymes AS (NSISb) is trading at a price of 411.7, with a previous close of 402.70. The stock has fluctuated within a day range of 403.2 to 411.7, while its 52-week range spans from 368.5 to 489.4.

What Is Novozymes AS (NSISb) Price Target According to Analysts?

The average 12-month price target for Novozymes AS is DKK478.6685, with a high estimate of DKK569 and a low estimate of DKK380. 11 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +16.27% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.